Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EDBL
EDBL logo

EDBL Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Edible Garden AG Inc (EDBL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.190
1 Day change
-5.01%
52 Week Range
31.300
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Edible Garden AG Inc (EDBL) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock shows no significant positive catalysts, weak technical indicators, and lacks strong trading signals. Additionally, the company's transition strategy and equity dilution present risks that may not align with a beginner's investment goals.

Technical Analysis

The MACD is slightly positive but contracting, indicating weak momentum. RSI is neutral at 42.77, suggesting no clear overbought or oversold conditions. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key pivot levels, with support at 0.196 and resistance at 0.23. Overall, the technical outlook is weak.

Positive Catalysts

  • The company is transitioning to a ready-to-drink protein/nutrition platform, which analysts view favorably. Additionally, the partnership with Structura Architects to develop a new production facility could enhance capacity and future growth.

Neutral/Negative Catalysts

  • The stock has faced equity dilution and execution risks, as reflected in the lowered price target by analysts. There are no significant trading trends from hedge funds or insiders, and the stock's recent performance shows a likelihood of further declines in the short term.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Maxim analyst Anthony Vendetti maintains a Buy rating but significantly lowered the price target to $1 (adjusted for a 1:10 reverse split), citing equity dilution and execution risks.

Wall Street analysts forecast EDBL stock price to rise
Analyst Rating
0
Wall Street analysts forecast EDBL stock price to rise
Buy
Hold
Sell
0
Current: 0.162
sliders
Low
0
Averages
0
High
0
0
Current: 0.162
sliders
Low
0
Averages
0
High
0
Maxim
Anthony Vendetti
Buy
downgrade
$80 -> $1
AI Analysis
2026-06-15
Reason
Maxim
Anthony Vendetti
Price Target
$80 -> $1
AI Analysis
2026-06-15
downgrade
Buy
Reason
Maxim analyst Anthony Vendetti lowered the firm's price target on Edible Garden to $1, with adjustment for 1:10 reverse split, from $80. The firm also keeps a Buy rating on the shares. The company is transitioning from controlled environment agriculture and fresh herbs toward a ready-to-drink protein/nutrition platform, which the firm views favorably, though its price target is reduced to reflect equity dilution and execution risk, the analyst tells investors in a research note.

People Also Watch